Kynurenines as a Novel Target for the Treatment of Malignancies
Malignancies are unquestionably a significant public health problem. Their effective treatment is still a big challenge for modern medicine. Tumors have developed a wide range of mechanisms to evade an immune and therapeutic response. As a result, there is an unmet clinical need for research on solu...
Main Authors: | Adrian Mor, Anna Tankiewicz-Kwedlo, Dariusz Pawlak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/7/606 |
Similar Items
-
Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
by: Adrian Mor, et al.
Published: (2021-06-01) -
The Kynurenine Pathway As a Novel Link between Allergy and the Gut Microbiome
by: Aaron P. Van der Leek, et al.
Published: (2017-11-01) -
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
by: Mariko Seishima, et al.
Published: (2021-10-01) -
The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
by: Knut A. Hestad, et al.
Published: (2017-10-01) -
Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
by: Concetta Elisa Onesti, et al.
Published: (2019-07-01)